Heat susceptibility of interleukin-10 and other cytokines in donor human milk

Breastfeeding Medicine

Volumn 4, Issue 3, 2009, Pages 137-144

  Untalan, Peter B ^a   Keeney, Susan E ^b   Palkowetz, Kimberly H ^b   Rivera, Audelio ^a   Goldman, Armond S ^b  

^a TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BREAST MILK; FEMALE; HEALTH CARE FACILITY; HUMAN; LACTATION; LYMPHOCYTE PROLIFERATION; MILK LEVEL; PASTEURIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; THERMAL EXPOSURE;

ADULT; ENTEROCOLITIS, NECROTIZING; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FEMALE; FOOD PRESERVATION; HOT TEMPERATURE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTERLEUKIN-10; LACTATION; MILK, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70349213586     PISSN: 15568253     EISSN: None     Source Type: Journal    
DOI: 10.1089/bfm.2008.0145     Document Type: Article

References (43)

1. Jesse N, Neu J. Necrotizing enterocolitis: Relationship to innate immunity, clinical features, and strategies for prevention. Neoreviews 2006;7:e143-e150.
2. Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990;336:1519-1523.
3. Goldman AS. Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective. J Nutr 2000;130(2S Suppl):426S-431S.
4. Nair RR, Warner BB, Warner BW. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis. Semin Perinatol 2008;32:107-113.
5. Donnet-Hughes A, Duc N, Serrant P, et al. Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-beta. Immunol Cell Biol 2000;78:74-79.
6. Fituch CC, Palkowetz KH, Goldman AS, et al. Concentrations of IL-10 in preterm human milk and in milk from mothers of infants with necrotizing enterocolitis. Acta Paediatr 2004;93:1496-1500.
7. Cohen RS. Current issues in human milk banking. Neoreviews 2007;8:e289-e295.
8. Tully MR JF, eds. Guidelines for the Establishment and Operation of a Human Donor Milk Bank. Human Milk Banking Association of North America, Raleigh, NC, 2003.
9. Tully DB, Jones F, Tully MR. Donor milk: What's in it and what's not. J Hum Lact 2001;17:152-155.
10. Ford JE, Law BA, Marshall VM, et al. Influence of the heat treatment of human milk on some of its protective constituents. J Pediatr 1977;90:29-35.
11. Evans TJ, Ryley HC, Neale LM, et al. Effect of storage and heat on antimicrobial proteins in human milk. Arch Dis Child 1978;53:239-241.
12. McGuire W, Anthony MY. Donor human milk versus formula for preventing necrotising enterocolitis in preterm in fants: Systematic review. Arch Dis Child Fetal Neonatal Ed 2003;88:F11-F14.
13. Jensen RG, ed. Handbook of Milk Composition. Academic Press, San Diego, 1995.
14. Juul SE, Zhao Y, Dame JB, et al. Origin and fate of erythropoietin in human milk. Pediatr Res 2000;48:660-667.
15. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992;148:1143-1148.
16. Dvorak B, Philips AF, Koldovsky O. Milk-borne growth factors and gut development. In: Zeigler EE, Lucas A, Moro GE, eds. Nutrition of the Very Low Birthweight Infant. Williams & Wilkins, Philadelphia, 1999, pp. 245-255.
17. Duh G, Mouri N, Warburton D, et al. EGF regulates early embryonic mouse gut development in chemically defined organ culture. Pediatr Res 2000;48:794-802.
18. Pollack PF, Goda T, Colony PC, et al. Effects of enterally fed epidermal growth factor on the small and large intestine of the suckling rat. Regul Pept 1987;17:121-132.
19. Clark JA, Doelle SM, Halpern MD, et al. Intestinal barrier failure during experimental necrotizing enterocolitis: Protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 2006;291:G938-G949.
20. Chang CJ, Chao JC. Effect of human milk and epidermal growth factor on growth of human intestinal Caco-2 cells. J Pediatr Gastroenterol Nutr 2002;34:394-401.
21. Clark JA, Lane RH, Maclennan NK, et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005;288:G755-G762.
22. Helmrath MA, Shin CE, Fox JW, et al. Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis. Lancet 1998;351:266-267.
23. Shin CE, Falcone RA Jr, Stuart L, et al. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 2000;35:173-176.
24. Warner BB, Ryan AL, Seeger K, et al. Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J Pediatr 2007;150:358-363.
25. Halpern MD, Holubec H, Clark JA, et al. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis. Biol Neonate 2006;89:227-235.
26. Sullivan PB, Lewindon PJ, Cheng C, et al. Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis. J Pediatr Surg 2007;42:462-469.
27. Jansson L, Karlson FA, Westermark B. Mitogenic activity and epidermal growth factor content in human milk. Acta Paediatr Scand 1985;74:250-253.
28. Dvorak B, Fituch CC, Williams CS, et al. Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res 2003;54:15-19.
29. Min KM, Kim PH. Macrophage-derived TGF-beta1 induces IgA isotype expression. Mol Cells 2003;16:245-250.
30. Planchon SM, Martins CA, Guerrant RL, et al. Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 1994;153:5730-5739.
31. Claud EC, Savidge T, Walker WA. Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res 2003;53:419-425.
32. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999;103:766-771.
33. McPherson RJ, Wagner CL. The effect of pasteurization on transforming growth factor alpha and transforming growth factor beta 2 concentrations in human milk. Adv Exp Med Biol 2001;501:559-566.
34. Juul SE, Joyce AE, Zhao Y, et al. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 1999;46:263-268.
35. Kling PJ. Roles of erythropoietin in human milk. Acta Paediatr Suppl 2002;91:31-35.
36. Ledbetter DJ, Juul SE. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg 2000;35:178-181; discussion 182.
37. Lappin TR, Elder GE, Taylor T, et al. Comparison of the mouse spleen cell assay and a radioimmunoassay for the measurement of serum erythropoietin. Br J Haematol 1988;70:117-120.
38. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
39. Lane JS, Todd KE, Lewis MP, et al. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion. Surgery 1997;122:288-294.
40. Ozturk H, Dokucu AI, Ogun C, et al. Protective effects of recombinant human interleukin-10 on intestines of hypoxia-induced necrotizing enterocolitis in immature rats. J Pediatr Surg 2002;37:1330-1333.
41. Kenis G, Teunissen C, De Jongh R, et al. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 2002;19:228-235.
42. Syto R, Murgolo NJ, Braswell EH, et al. Structural and biological stability of the human interleukin 10 homodimer. Biochemistry 1998;37:16943-16951.
43. Garofalo R, Chheda S, Mei F, et al. Interleukin-10 in human milk. Pediatr Res 1995;37:444-449.